Patients with the myeloproliferative neoplasms (MPNs) myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia (ET) are at increased risk for thrombotic and cardiovascular events and experience a variety of burdensome symptoms. | Impact of Myeloproliferative neoplasms on patients employment status and work productivity in the United States Results from the living with MPNs survey